[{"AccountsPayableCurrent_0_Q1_USD":1548309.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":-4250780.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":222513.0,"PaymentsOfFinancingCosts_1_Q1_USD":5740.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":3940.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":369499.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":222513.0,"OtherLiabilitiesCurrent_0_Q1_USD":206415.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q1_USD":0.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1_Q1_USD":0.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":3344288.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1_Q1_USD":0.42,"ProceedsFromLongTermLinesOfCredit_1_Q1_USD":500000.0,"InvestmentIncomeInterest_1_Q1_USD":119.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-3943819.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":1459.0,"OtherAssetsNoncurrent_0_Q1_USD":551163.0,"NonoperatingIncomeExpense_1_Q1_USD":-14717.0,"LongTermDebtNoncurrent_0_Q1_USD":1580560.0,"TreasuryStockValue_0_Q1_USD":47864.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0_Q1_USD":1400000.0,"FinanceLeaseLiability_0_Q1_USD":26555.0,"FinanceLeaseLiabilityPaymentsDueYearTwo_0_Q1_USD":3977.0,"RestrictedCashNoncurrent_0_Q1_USD":151100.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q1_pure":0.076,"OperatingLeaseRightOfUseAsset_0_Q1_USD":302990.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":117142.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":176616.0,"OperatingLeaseLiability_0_Q1_USD":293758.0,"OperatingLeaseCost_1_Q1_USD":47696.0,"LiabilitiesFairValueAdjustment_1_Q1_USD":0.0,"FinanceLeaseLiabilityPaymentsDue_0_Q1_USD":27833.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q1_USD":22674.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q1_USD":160909.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q1_USD":11354.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q1_USD":316432.0,"LesseeFinanceLeaseDiscountRate_0_Q1_pure":0.076,"LeaseCost_1_Q1_USD":68865.0,"FinanceLeasePrincipalPayments_1_Q1_USD":5964.0,"FinanceLeaseLiabilityUndiscountedExcessAmount_0_Q1_USD":1278.0,"FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q1_USD":23856.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q1_USD":144169.0,"TreasuryStockCommonShares_0_Q1_shares":121500.0,"AssetsHeldForSaleNotPartOfDisposalGroupCurrent_0_Q1_USD":7000000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_1_Q1_USD":-1225853.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-52653.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":488296.0,"LiabilitiesNoncurrent_0_Q1_USD":1701642.0,"LiabilitiesCurrent_0_Q1_USD":3314998.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":12313745.0,"Liabilities_0_Q1_USD":5016640.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":-227870.0,"GeneralAndAdministrativeExpense_1_Q1_USD":2276784.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-4686423.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-0.07,"CommonStockValue_0_Q1_USD":527467.0,"CommonStockSharesOutstanding_0_Q1_shares":52625228.0,"CommonStockSharesIssued_0_Q1_shares":52746728.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":3193188.0,"AssetsCurrent_0_Q1_USD":11362485.0,"Assets_0_Q1_USD":12313745.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":12140719.0,"AdditionalPaidInCapital_0_Q1_USD":62241145.0,"Depreciation_1_Q1_USD":18283.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":-87.0,"NetIncomeLoss_1_Q1_USD":-3943819.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":1169297.0,"ResearchAndDevelopmentExpense_1_Q1_USD":1652318.0,"PreferredStockValue_0_Q1_USD":0.0,"PreferredStockSharesOutstanding_0_Q1_shares":7.0,"PreferredStockSharesIssued_0_Q1_shares":7.0,"PreferredStockSharesAuthorized_0_Q1_shares":10000000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.01,"OperatingIncomeLoss_1_Q1_USD":-3929102.0,"OperatingExpenses_1_Q1_USD":3929102.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":52653.0,"InterestExpense_1_Q1_USD":14749.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.01,"CommitmentsAndContingencies_0_Q1_USD":null,"AccruedLiabilitiesCurrent_0_Q1_USD":1383658.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":52627228.0,"StockholdersEquity_0_Q1_USD":7297105.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-55423643.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":248997.0,"ProfitLoss_1_Q1_USD":-3943819.0,"CommonStockSharesAuthorized_0_Q1_shares":200000000.0,"VariableLeaseCost_1_Q1_USD":21169.0,"Ticker":"OCGN","CIK":"1372299","name":"OCUGEN, INC.","OfficialName":"Ocugen Inc. Common Stock","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"583661968.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200508"}]